Epigenetic targets of arsenic: Emphasis on epigenetic modifications during carcinogenesis

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 34, Issue 1, 2015, Pages 63-84

  Roy, Ram Vinod ^a   Son, Young Ok ^a   Pratheeshkumar, Poyil ^a   Wang, Lei ^a   Hitron, John Andrew ^a   Divya, Sasidharan Padmaja ^a   Rakesh, D ^a   Kim, Donghern ^a   Yin, Yuanqin ^a   Zhang, Zhuo ^a   Shi, Xianglin ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Arsenic; Carcinogenesis; Chromatin; DNA methylation; Epigenetics; Epigenome; Histone modification; Intergeneration; MiRNAs; Prenatal exposure; Transgenerational

Indexed keywords

ARSENIC; MICRORNA; RNA POLYMERASE II; HISTONE;

ARSENIC POISONING; ARTICLE; CARCINOGENESIS; CHROMATIN STRUCTURE; DNA METHYLATION; DNA MODIFICATION; DOWN REGULATION; EPIGENETICS; GENE TARGETING; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; UPREGULATION; ANIMAL; GENETIC EPIGENESIS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ARSENIC; CARCINOGENESIS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; MICE; MICRORNAS; PROMOTER REGIONS, GENETIC;

EID: 84924415460     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.2014012066     Document Type: Article

References (140)

1. Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull WHO. 2000;78(9):1093-103.
2. Koestler DC, Avissar-Whiting M, Houseman EA, Karagas MR, Marsit CJ. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Envir Health Persp. 2013;121(8):971-7.
3. Pilsner JR, Hall MN, Liu X, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Yunus M, Rahman M, Graziano JH, Gamble MV. Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PLoS One. 2012;7(5):e37147.
4. Asadullah MN, Chaudhury N. Poisoning the mind: arsenic contamination of drinking water wells and children’s educational achievement in rural Bangladesh. Econ Educ Rev. 2011;30(5):873-88.
5. Rossman TG, Klein CB. Genetic and epigenetic effects of environmental arsenicals. Metallomics. 2011;3(11):1135-41.
6. Smith AH, Hopenhaynrich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Envir Health Persp. 1992;97:259-67.
7. Smith A, Lopipero P, Chung J, Haque R, Hernandez A, Moore L. Arsenic in drinking water and cancer risks estimated from epidemiological studies in Argentina, Chile, Taiwan and Japan. Epidemiology. 2000;11(4):93.
8. Petrick JS, Jagadish B, Mash EA, Aposhian HV. Monomethylarsonous acid (MMA(III)) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol. 2001;14(6):651-6.
9. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Envir Health Persp. 2002;110: 767-71.
10. Rossman TG. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res-Fund Mol M. 2003;533(1-2):37-65.
11. Moore LE, Smith AH, HopenhaynRich C, Biggs ML, Kalman DA, Smith MT. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidem Biomar. 1997;6(1):31-6.
12. Moore LE, Smith AH, Eng C, Kalman D, DeVries S, Bhargava V, Chew K, Moore D, Ferreccio C, Rey OA, Waldman FM. Arsenic-related chromosomal alterations in bladder cancer. J Nat Cancer Insti. 2002;94(22):1688-96.
13. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Envir Health Persp. 2011;119(1):11-9.
14. Tang WY, Ho SM. Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord. 2007;8(2):173-82.
15. Nanney DL. Epigenetic control systems. Proc Natl Acad Sci U S A. 1958;44(7):712-7.
16. Nise MS, Falaturi P, Erren TC. Epigenetics: origins and implications for cancer epidemiology. Med Hypoth. 2010;74(2):377-82.
17. Kumagai Y, Sumi D. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Ann Rev Pharmacol Toxicol. 2007;47:243-62.
18. Hei TK, Filipic M. Role of oxidative damage in the genotoxicity of arsenic. Free Radical Biol Med. 2004;37(5): 574-81.
19. Reichard JF, Puga A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics UK. 2010;2(1):87-104.
20. Mass MJ, Wang LJ. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res-Rev Mutat. 1997;386(3):263-77.
21. Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A. 2000;97(10):5237-42.
22. Ziller MJ, Muller F, Liao J, Zhang YY, Gu HC, Bock C, Boyle P, Epstein CB, Bernstein BE, Lengauer T, Gnirke A, Meissner A. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet. 2011;7(12).
23. Deaton AM, Bird A. CpG islands and the regulation of transcription. Gene Dev. 2011;25(10):1010-22.
24. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nature Rev Genet. 2013;14(3): 204-20.
25. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247-57.
26. Chedin F, Lieber MR, Hsieh CL. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc Natl Acad Sci U S A. 2002;99(26):16916-21.
27. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69(6):915-26.
28. Caudill MA, Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, Santos-Guzman J, Swendseid ME, Cogger EA, James SJ. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J Nutr. 2001;131(11):2811-8.
29. Goering PL, Aposhian HV, Mass MJ, Cebrian M, Beck BD, Waalkes MP. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci. 99;49(1):5-14.
30. Coppin JF, Qu W, Waalkes MP. Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells. J Biol Chem. 2008;283(28):19342-50.
31. Reichard JF, Schnekenburger M, Puga A. Long-term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Comm. 2007;352(1):188-92.
32. Cui X, Wakai T, Shirai Y, Yokoyama N, Hatakeyama K, Hirano S. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Human Pathol. 2006;37(3): 298-311.
33. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A. 1997;94(20):10907-12.
34. Chen H, Liu J, Merrick BA, Waalkes MP. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Molec Carcinogen. 2001;30(2):79-87.
35. Treas JN, Tyagi T, Singh KP. Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cells. PLoS One. 2012;7(8):e43880.
36. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv Nutr. 2012;3(1):21-38.
37. Gamble MV, Liu X, Slavkovich V, Pisner JR, Ilievski V, Factor-Litvak P, Levy D, Alam S, Islam M, Parvez F, Ahsan H, Graziano JH. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr. 2007;86(4):1202-9.
38. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Graziano JH, Gamble MV. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr. 2007;86(4):1179-86.
39. Kile ML, Ronnenberg AG. Can folate intake reduce arsenic toxicity? Nutr Rev. 2008;66(6):349-53.
40. Majumdar S, Chanda S, Ganguli B, Mazumder DN, Lahiri S, Dasgupta UB. Arsenic exposure induces genomic hypermethylation. Envir Toxicol. 2010;25(3):315-8.
41. Yang AS, Estecio MRH, Doshi K, Kondo Y, Tajara EH, Issa JPJ. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acid Res. 2004;32(3).
42. Lambrou A, Baccarelli A, Wright RO, Weisskopf M, Bollati V, Amarasiriwardena C, Vokonas P, Schwartz J. Arsenic exposure and DNA methylation among elderly men. Epidemiology. 2012;23(5):668-76.
43. Walter U, Santamaria P. CD8+ T cells in autoimmunity. Curr Opin Immunol. 2005;17(6):624-31.
44. Niedzwiecki MM, Hall MN, Liu X, Oka J, Harper KN, Slavkovich V, Ilievski V, Levy D, van Geen A, Mey JL, Alam S, Siddique AB, Parvez F, Graziano JH, Gamble MV. A dose-response study of arsenic exposure and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults. Envir Health Persp. 2013;121(11-12):1306-12.
45. Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, Waalkes MP. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology. 2007;236(1-2):7-15.
46. Chen H, Li SF, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis. 2004;25(9):1779-86.
47. Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicology and applied pharmacology. 2001;175(3):260-8.
48. Xu YF, Wu FZ, Tan L, Kong LC, Xiong LJ, Deng J, Barbera AJ, Zheng L, Zhang H, Huang S, Min J, Nicholson T, Chen T, Xu G, Shi Y, Zhang K, Shi YG. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell. 2011;42(4):451-64.
49. Tellez-Plaza M, Tang WY, Shang Y, Umans JG, Francesconi KA, Goessler W, Ledesma M, Leon M, Laclaustra M, Pollak J, Guallar E, Cole SA, Fallin MD, Navas-Acien A. Association of global DNA methylation and global DNA hydroxymethylation with metals and other exposures in human blood DNA samples. Envir Health Persp. 2014;122(9):946-54.
50. Chen PL, Cheng YW, Chiang CC, Tseng SH, Chau PS, Tsai YY. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b. Molec Vis. 2006;12:1411-6.
51. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006;89(2):431-7.
52. Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis. 2006;27(1):112-6.
53. Hossain MB, Vahter M, Concha G, Broberg K. Environmental arsenic exposure and DNA methylation of the tumor suppressor gene p16 and the DNA repair gene MLH1: effect of arsenic metabolism and genotype. Metallomics. 2012;4(11):1167-75.
54. Chen WT, Hung WC, Kang WY, Huang YC, Chai CY. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase. Histopathology. 2007;51(6):785-92.
55. Paul S, Banerjee N, Chatterjee A, Sau TJ, Das JK, Mishra PK, Chakrabarti P, Bandyopadhyay A, Giri AK. Arsenic-induced promoter hypomethylation and over-expression of ERCC2 reduces DNA repair capacity in humans by non-disjunction of the ERCC2-Cdk7 complex. Metallomics. 2014;6(4):864-73.
56. Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Gene Dev. 2011;25(5):409-33.
57. Bailey KA, Wu MC, Ward WO, Smeester L, Rager JE, Garcia-Vargas G, Del Razo LM, Drobná Z, Stýblo M, Fry RC. Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Molec Toxicol. 2013;27(2):106-15.
58. Wang S, Li X, Song X, Geng Z, Hu X, Wang Z. Rapid equilibrium kinetic analysis of arsenite methylation catalyzed by recombinant human arsenic (+3 oxidation state) methyltransferase (hAS3MT). J Biol Chem. 2012;287(46):38790-9.
59. Wang SP, Li XL, Song XL, Geng ZR, Hu X, Wang ZL. Rapid equilibrium kinetic analysis of arsenite methylation catalyzed by recombinant human arsenic (+3 oxidation state) methyltransferase (hAS3MT). J Biol Chem. 2012;287(46):38790-9.
60. Gribble MO, Tang WY, Shang Y, Pollak J, Umans JG, Francesconi KA, Goessler W, Silbergeld EK, Guallar E, Cole SA, Fallin MD, Navas-Acien A. Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure. Arch Toxicol. 2014;88(2):275-82.
61. Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou YS, Cheng ML, Diwan BA. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Nat Cancer Inst. 2004;96(6):466-74.
62. Okoji RS, Yu RC, Maronpot RR, Froines JR. Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice. Carcinogenesis. 2002;23(5):777-85.
63. Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol Sci. 2006;91(2):372-81.
64. Ramakrishnan V. Histone structure and the organization of the nucleosome. Annu Rev Bioph Biom. 1997;26:83-112.
65. Roy RV, Suman S, Das TP, Luevano JE, Damodaran C. Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells. J Nat Prod. 2013;76(10):1909-15.
66. Buning R, Koopmans W, Neumann H, Chin J, van Noort J. Regulation of nucleosome conformational dynamics by post-translational histone modifications studied with single-pair FRET. Biophys J. 2010;98(3):475.
67. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693-705.
68. Jaskelioff M, Gavin IM, Peterson CL, Logie C. SWI-SNF-mediated nucleosome remodeling: role of histone octamer mobility in the persistence of the remodeled state. Mol Cell Biol. 2000;20(9):3058-68.
69. Chen H, Li BY, Workman JL. A histone-binding protein, nucleoplasmin, stimulates transcription factor-binding to nucleosomes and factor-induced nucleosome disassembly. Embo J. 1994;13(2):380-90.
70. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol R. 2000;64(2):435.
71. Cress WD, Seto E. Histone deacetylases, transcriptional control, and cancer. J Cell Physiol. 2000;184(1):1-16.
72. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 1998;12(5):599-606.
73. Ramirez T, Brocher J, Stopper H, Hock R. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. Chromosoma. 2008;117(2):147-57.
74. Hong GM, Bain LJ. Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1. Toxicol Appl Pharmacol. 2012;260(3):250-9.
75. Jo WJ, Ren X, Chu F, Aleshin M, Wintz H, Burlingame A, Smith MT, Vulpe CD, Zhang L. Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure. Toxicol Appl Pharmacol. 2009;241(3):294-302.
76. Chu F, Ren X, Chasse A, Hickman T, Zhang L, Yuh J, Smith MT, Burlingame AL. Quantitative mass spectrometry reveals the epigenome as a target of arsenic. Chemico-biological interactions. 2011;192(1-2): 113-7.
77. Chervona Y, Hall MN, Arita A, Wu F, Sun H, Tseng HC, Ali E, Uddin MN, Liu X, Zoroddu MA, Gamble MV, Costa M. Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh. Cancer Epidem Biomar. 2012;21(12):2252-60.
78. Cantone L, Nordio F, Hou L, Apostoli P, Bonzini M, Tarantini L, Angelici L, Bollati V, Zanobetti A, Schwartz J, Bertazzi PA, Baccarelli A. Inhalable metal-rich air particles and histone H3K4 dimethylation and H3K9 acetylation in a cross-sectional study of steel workers. Envir Health Persp. 2011;119(7):964-9.
79. Cronican AA, Fitz NF, Carter A, Saleem M, Shiva S, Barchowsky A, Koldamova R, Schug J, Lefterov I. Genome-wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic. PLoS One. 2013;8(2):e53478.
80. Teperino R, Schoonjans K, Auwerx J. Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab. 2010;12(4):321-7.
81. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nature Revs Molec Cell Biol. 2005;6(11):838-49.
82. Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell. 2007;25(1):1-14.
83. Arrigo AP. Acetylation and methylation patterns of core histones are modified after heat or arsenite treatment of Drosophila tissue culture cells. Nucleic Acid Res. 1983;11(5):1389-404.
84. Zhou X, Li Q, Arita A, Sun H, Costa M. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol. 2009;236(1):78-84.
85. Jensen TJ, Wozniak RJ, Eblin KE, Wnek SM, Gandolfi AJ, Futscher BW. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol. 2009;235(1):39-46.
86. Suzuki T, Nohara K. Long-term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16(INK4a) and down-regulates its expression in the liver of mice. J Appl Toxicol. 2013;33(9):951-8.
87. Bracht J, Hunter S, Eachus R, Weeks P, Pasquinelli AE. Trans-splicing and polyadenylation of let-7 microRNA primary transcripts. RNA-A. 2004;10(10):1586-94.
88. Cai XZ, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA-A. 2007;13(3):313-6.
89. Han JJ, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Gene Devel. 2004;18(24):3016-27.
90. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trend Cell Biol. 2007;17(3):118-26.
91. Morlando M, Ballarino M, Gromak N, Pagano F, Bozzoni I, Proudfoot NJ. Primary microRNA transcripts are processed co-transcriptionally. Nature Struct Molec Biol. 2008;15(9):902-9.
92. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLOS Biol. 2004;2(11):1862-79.
93. Lee Y, Kim M, Han JJ, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004;23(20):4051-60.
94. Cohen SM. Reply to “Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b.” Toxicol Sci. 2011;122(2):606; author reply 7-9.
95. Wang Z, Humphries B, Xiao H, Jiang Y, Yang C. MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase C-alpha and Wnt5b-protein kinase C-alpha positive feedback loop and inhibiting Rac1 activation. J Biol Chem. 2014;289(26):18373-86.
96. Jiang R, Li Y, Zhang A, Wang B, Xu Y, Xu W, Zhao Y, Luo F, Liu Q. The acquisition of cancer stem cell-like properties and neoplastic transformation of human keratinocytes induced by arsenite involves epigenetic silencing of let-7c via Ras/NF-kappaB. Toxic Lett. 2014;227(2):91-8.
97. Ngalame NN, Tokar EJ, Person RJ, Xu Y, Waalkes MP. Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic. Toxicol Sci. 2014;138(2):268-77.
98. Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA, Jo SH, Kim TH, Min HS, Chae JS, Choi EJ, Kim G, Shin SH, Gwak HS, Kim SK, Hong EK, Lee GK, Choi KH, Kim JH, Yoo H, Park JB, Lee SH. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene. 2011;30(21):2433-42.
99. Ling M, Li Y, Xu Y, Pang Y, Shen L, Jiang R, Zhao Y, Yang X, Zhang J, Zhou J, Wang X, Liu Q. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-kappaB in arsenite-induced cell transformation. Free Radical Biol Med. 2012;52(9): 1508-18.
100. Cui Y, Han Z, Hu Y, Song G, Hao C, Xia H, Ma X. MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1. J Cell Physiol. 2012;227(2):772-83.
101. Beezhold K, Liu J, Kan H, Meighan T, Castranova V, Shi X, Chen F. miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol Sci. 2011;123(2):411-20.
102. Rager JE, Bailey KA, Smeester L, Miller SK, Parker JS, Laine JE, Drobná Z, Currier J, Douillet C, Olshan AF, Rubio-Andrade M, Stýblo M, García-Vargas G, Fry RC. Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. Envir Molec Mutagen. 2014;55(3):196-208.
103. Marsit CJ, Eddy K, Kelsey KT. MicroRNA responses to cellular stress. Cancer Res. 2006;66(22):10843-8.
104. Anway MD. Epigenetic transgenerational actions of endocrine disruptors and male fertility (June, pg 1466, 2005). Science. 2010;328(5979):690-.
105. Cesani MF, Orden B, Zucchi M, Mune MC, Oyhenart EE, Pucciarelli HM. Effect of undernutrition on the cranial growth of the rat—an intergenerational study. Cell Tiss Organ. 2003;174(3):129-35.
106. Newbold RR, Padilla-Banks E, Jefferson WN. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology. 2006;147(6):S11-S7.
107. Popova NV. Transgenerational effect of orthoaminoasotoluol in mice. Cancer Lett. 1989;46(3):203-6.
108. Yamasaki H, Loktionov A, Tomatis L. Perinatal and multigenerational effect of carcinogens—possible contribution to determination of cancer susceptibility. Envir Health Persp. 1992;98:39-43.
109. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308(5727):1466-9.
110. Anway MD, Leathers C, Skinner MK. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology. 2006;147(12):5515-23.
111. Nilsson EE, Anway MD, Stanfield J, Skinner MK. Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease. Reproduction. 2008;135(5):713-21.
112. Heard E, Martienssen RA. Transgenerational epigenetic inheritance: myths and mechanisms. Cell. 2014;157(1):95-109.
113. Lumey LH. Decreased birthweights in infants after maternal in utero exposure to the Dutch famine of 1944-1945. Paediatr Perinat Epidemiol. 1992;6(2):240-53.
114. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. New Eng J Med. 1976;295(7):349-53.
115. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Nat Acad Sci U S A. 2008;105(44): 17046-9.
116. Martin JF, Johnston CS, Han CT, Benyshek DC. Nutritional origins of insulin resistance: a rat model for diabetes-prone human populations. J Nutr. 2000; 130(4):741-4.
117. Benyshek DC, Johnston CS, Martin JF. Glucose metabolism is altered in the adequately nourished grand-offspring (F-3 generation) of rats malnourished during gestation and perinatal life. Diabetologia. 2006;49(5):1117-9.
118. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008;105(44):17046-9.
119. Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK. Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations. PLoS One. 2012;7(9):e46249.
120. Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK. Plastics-derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. PLoS One. 2013;8(1):e55387.
121. Dunn GA, Bale TL. Maternal high-fat diet effects on third-generation female body size via the paternal lineage. Endocrinology. 2011;152(6):2228-36.
122. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrin Met. 2010;21(4):214-22.
123. Guerrero-Bosagna C, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of phenotype and disease. Molec Cell Endocrinol. 2012;354(1-2):3-8.
124. Santos F, Hendrich B, Reik W, Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol. 2002;241(1):172-82.
125. Davis TL, Trasler JM, Moss SB, Yang GJ, Bartolomei MS. Acquisition of the H19 methylation imprint occurs differentially on the parental alleles during spermatogenesis. Genomics. 1999;58(1):18-28.
126. Liu J, Xie YX, Cooper R, Duchanne DMK, Tennant R, Diwan BA, Waalkes MP. Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol Appl Pharmacol. 2007;220(3):284-91.
127. Jin YP, Xi SH, Li X, Lu CN, Li GX, Xu YY, Qu C, Niu Y, Sun G. Arsenic speciation transported through the placenta from mother mice to their newborn pups. Environ Res. 2006;101(3):349-55.
128. Waalkes MP, Liu J, Ward JM, Diwan BA. Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol Appl Pharmacol. 2006;215(3):295-305.
129. Nohara K, Suzuki T, Takumi S, Okamura K. Increase in incidence of hepatic tumors caused by oncogenic somatic mutation in mice maternally exposed to inorganic arsenic and the multigenerational and transgenerational effects of inorganic arsenic. Jap J Hygiene. 2014;69(2):92-6.
130. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Graziano JH, Gamble MV. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Envir Health Persp. 2009;117(2):254-60.
131. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol. 2005;206(3):288-98.
132. Sciandrello G, Caradonna F, Mauro M, Barbata G. Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis. 2004;25(3):413-7.
133. Intarasunanont P, Navasumrit P, Waraprasit S, Chaisatra K, Suk WA, Mahidol C, Ruchirawat M. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health-Glob. 2012;11.
134. Engstrom KS, Hossain MB, Lauss M, Ahmed S, Raqib R, Vahter M, Broberg K. Efficient arsenic metabolism—the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. PLoS One. 2013;8(1).
135. Jensen TJ, Novak P, Eblin KE, Gandolfi AJ, Futscher BW. Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis. 2008;29(8):1500-8.
136. Chai CY, Huang YC, Hung WC, Kang WY, Chen WT. Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells. Toxicol Letts. 2007; 173(1):48-56.
137. Fu HY, Shen JZ. [Hypermethylation of CpG island of p16 gene and arsenic trioxide induced p16 gene demethylation in multiple myeloma]. Zhonghua nei ke za zhi. 2005;44(6):411-4.
138. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutation Res. 1997;386(3):263-77.
139. Zhou X, Sun H, Ellen TP, Chen H, Costa M. Arsenite alters global histone H3 methylation. Carcinogenesis. 2008;29(9):1831-6.
140. Li J, Gorospe M, Barnes J, Liu Y. Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. J Biol Chem. 2003;278(15):13183-91.